<SEC-DOCUMENT>0001683168-25-004556.txt : 20250617
<SEC-HEADER>0001683168-25-004556.hdr.sgml : 20250617
<ACCEPTANCE-DATETIME>20250617172435
ACCESSION NUMBER:		0001683168-25-004556
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20250617
DATE AS OF CHANGE:		20250617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forward Industries, Inc.
		CENTRAL INDEX KEY:			0000038264
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS PRODUCTS, NEC [3089]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				131950672
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287906
		FILM NUMBER:		251054391

	BUSINESS ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788
		BUSINESS PHONE:		631-547-3055

	MAIL ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FORWARD INDUSTRIES INC
		DATE OF NAME CHANGE:	19950105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROGRESS HEAT SEALING CO INC
		DATE OF NAME CHANGE:	19721111
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forward_s1a1.htm
<DESCRIPTION>PRE-EFFECTIVE AMENDMENT NO. 1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:FORD="http://forwardindus.com/20250617">
<head>
     <title>Forward Industries, Inc. S-1/A</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_FORD_forwardindus.com_20250617 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250617_20250617 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000038264 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000004" name="dei:EntityCentralIndexKey">0000038264</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-17" id="xdx2ixbrl0009" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ford-20250617.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-17</xbrli:startDate>
        <xbrli:endDate>2025-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 7pt"><a href="#s1_001">Table of Contents</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on June 17, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-287906</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRE-EFFECTIVE AMENDMENT NO. 1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_dxL_c20250617__20250617_zaGnXRoMH1Z4" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0009">S-1</span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><img src="image_001.jpg" alt="" style="height: 95px; width: 174px"/></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20250617__20250617_zPGg3WUCBZIh" style="font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000010" name="dei:EntityRegistrantName">Forward
    Industries, Inc.</ix:nonNumeric></b></span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Exact Name of Registrant As Specified In Its Charter)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20250617__20250617_zgX4cvJwpq76"><ix:nonNumeric contextRef="AsOf2025-06-17" format="ixt-sec:stateprovnameen" id="Fact000011" name="dei:EntityIncorporationStateCountryCode">New York</ix:nonNumeric></span></b></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b>8711</b></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20250617__20250617_zCQp9H6PEowh"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000012" name="dei:EntityTaxIdentificationNumber">13-1950672</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State Or Other Jurisdiction Of Incorporation Or Organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Primary Standard Industrial<br/>
Classification Code Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer<br/>
Identification Number)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20250617__20250617_zNhvYyfD17yf"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000013" name="dei:EntityAddressAddressLine1">700 Veterans Memorial Highway</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressAddressLine2_c20250617__20250617_zYFG4wTK0ZEe"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000014" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20250617__20250617_zAN9NOzHhW2e"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000015" name="dei:EntityAddressCityOrTown">Hauppauge</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20250617__20250617_zauG0XH0217a"><ix:nonNumeric contextRef="AsOf2025-06-17" format="ixt-sec:stateprovnameen" id="Fact000016" name="dei:EntityAddressStateOrProvince">New
    York</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250617__20250617_zYR4juR3fhha"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000017" name="dei:EntityAddressPostalZipCode">11788</ix:nonNumeric></span></b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><b><span id="xdx_905_edei--CityAreaCode_c20250617__20250617_ze1gK6pc76R4"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000018" name="dei:CityAreaCode">(631)</ix:nonNumeric></span>&#160;<span id="xdx_909_edei--LocalPhoneNumber_c20250617__20250617_ztuJP2ROzaKk"><ix:nonNumeric contextRef="AsOf2025-06-17" id="Fact000019" name="dei:LocalPhoneNumber">547-3055</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Address, Including Zip Code, And Telephone Number, Including Area Code, Of Registrant&#8217;s Principal Executive Offices)</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>Kathleen Weisberg</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>Chief Financial Officer</b></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>700 Veterans Memorial Highway</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Suite 100</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Hauppauge, New York 11788</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>(631)&#160;547-3055 </b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Name, Address, Including Zip Code, And Telephone Number, Including Area Code, Of Agent for Service)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COPIES TO:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Brian S. Bernstein,
Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Brian A. Pearlman,
Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Nason Yeager Gerson
Harris &amp; Fumero P.A.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>3001 PGA Blvd., Suite
305</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Palm Beach Gardens,
Florida 33410</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>(561) 686-3307</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APPROXIMATE DATE
OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As soon as practicable
after this Registration Statement becomes effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
box: <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is used to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and "emerging growth company" in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 29%; text-align: justify">Large accelerated filer </td>
    <td style="width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="width: 37%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 24%; text-align: justify">Accelerated filer </td>
    <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_906_edei--EntityFilerCategory_c20250617__20250617_zpwNMWH8wwv5"><ix:nonNumeric contextRef="AsOf2025-06-17" format="ixt-sec:entityfilercategoryen" id="Fact000020" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> </td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify">Smaller reporting company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_edei--EntitySmallBusiness_c20250617__20250617_zXP9nMAH0qG5"><ix:nonNumeric contextRef="AsOf2025-06-17" format="ixt:booleantrue" id="Fact000021" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Emerging growth company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20250617__20250617_zlODJInq3Wk8"><ix:nonNumeric contextRef="AsOf2025-06-17" format="ixt:booleanfalse" id="Fact000022" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The registrant hereby amends this registration
statement on such date or date(s) as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, or until the registration statement shall become effective on such date as the Commission acting pursuant to said Section
8(a) may determine.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this prospectus is not complete
and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission
of which this prospectus is a part becomes effective. This prospectus is not an offer to sell these securities and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subject to Completion, dated June 17,
2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward Industries, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>273,000 Shares of Common Stock </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus relates to the
potential resale from time to time by C/M Capital Master Fund, LP (the &#8220;Selling Stockholder&#8221;) of up to 273,000 shares of common
stock, par value $0.01 per share. The shares of common stock to which this prospectus relates consist of shares that have been or may
be issued by us to the Selling Stockholder pursuant to a Securities Purchase Agreement, dated as of May 16, 2025, by and between us and
the Selling Stockholder (the &#8220;Purchase Agreement&#8221;), establishing an equity line of credit. Such shares of our common stock
include (i) up to 245,571 shares of common stock, or the Purchase Shares, that we may elect, in our sole discretion, subject to the restrictions
and satisfaction of the conditions in the Purchase Agreement, to issue and sell to the Selling Stockholder, from time to time from and
after the Commencement Date (as defined below) under the Purchase Agreement, and subject to applicable stock exchange rules and (ii) up
to 27,429 shares of common stock, or the Commitment Shares, that have or may be issued to the Selling Stockholder in connection with related
issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s execution and delivery of the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The actual number of shares of
our common stock issuable will vary depending on the then-current market price of shares of our common stock sold to the Selling Stockholder
under the Purchase Agreement, but will not exceed the number set forth in the preceding paragraphs unless we file an additional registration
statement under the Securities Act of 1933 (&#8220;Securities Act&#8221;), with the Securities and Exchange Commission (&#8220;SEC&#8221;),
and we obtain the approval of the issuance of shares of common stock by our stockholders in accordance with the applicable stock exchange
rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the applicable rules of
The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;), in no event may we issue to the Selling Stockholder shares of our common stock representing
more than 19.99% of the total number of shares of common stock outstanding as of the date of the Purchase Agreement, unless (i) we obtain
the approval of the issuance of such shares by our stockholders in accordance with the applicable stock exchange rules or (ii) the average
price paid for all shares of common stock issued under the Purchase Agreement (including both Purchase Shares and Commitment Shares) is
equal to or greater than $7.10, which is a price equal to the lower of (A) the Nasdaq Official Closing Price immediately preceding the
execution of the Purchase Agreement and (B) the average Nasdaq Official Closing Price of our common stock for the five trading days immediately
preceding the execution of the Purchase Agreement, as calculated in accordance with the rules of Nasdaq, such that the sales of such common
stock to the Selling Stockholder would not count toward such limit because they are &#8220;at market&#8221; under applicable stock exchange
rules. See &#8220;<i>The Committed Equity Financing</i>&#8221; for a description of the Purchase Agreement and &#8220;<i>Selling Stockholder</i>&#8221;
for additional information regarding the Selling Stockholder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not selling any securities
under this prospectus and will not receive any of the proceeds from the sale of the shares of our common stock by the Selling Stockholder.
Additionally, we will not receive any proceeds from the issuance or sale of any Commitment Shares. However, we may receive up to $35 million
in aggregate gross proceeds from the sale of the shares of common stock to the Selling Stockholder under the Purchase Agreement, from
time to time in our discretion, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, after the date
the registration statement that includes this prospectus is declared effective and after satisfaction of other conditions in the Purchase
Agreement. The actual proceeds from the Selling Stockholder may be less than this amount depending on the number of shares of our common
stock sold and the price at which the shares of our common stock are sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder may
offer, sell or distribute all or a portion of the shares of our common stock acquired under the Purchase Agreement and hereby registered
publicly or through private transactions at prevailing market prices or at negotiated prices. We will bear all costs, expenses and fees
in connection with the registration of the shares of our common stock, including with regard to compliance with state securities or &#8220;blue
sky&#8221; laws. The Selling Stockholder will bear all commissions and discounts, if any, attributable to its sale of shares of our common
stock. See &#8220;<a href="#s1_012"><i>Plan of Distribution</i></a>&#8221; for more information about how the Selling Stockholder may sell or otherwise
dispose of the shares of common stock being registered pursuant to this prospectus. The Selling Stockholder is an underwriter under the
Securities Act with respect to the resale of shares held by it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this prospectus
and any prospectus supplement or amendment, together with additional information described under the headings &#8220;<a href="#s1_017">Where You Can Find More Information</a>&#8221;, carefully before you invest in our securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221; On June 9, 2025, the last reported sales price of our common stock on
The Nasdaq Capital Market was $6.47 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Investing in our securities
involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#8220;<i><a href="#s1_006">Risk
Factors</a></i>&#8221; beginning on page 6 of this prospectus, and under similar headings in any amendment or supplement to this prospectus
or in any other documents incorporated by reference into this prospectus.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>NEITHER THE SECURITIES
AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY
OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">The date of this prospectus
is June [<span style="font-family: Symbol">&#183;</span>], 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_001"></span>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 93%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 7%"><b>Page</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_002">About This Prospectus</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_003">Cautionary Statement Regarding Forward Looking Statements</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_004">Prospectus Summary</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_005">The Offering</a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_006">Risk Factors</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_007">The Committed Equity Financing</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">11</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_008">Use of Proceeds</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_009">Market Information</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_010">Dividend Policy</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_011">The Selling Stockholder</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">17</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_012">Plan of Distribution</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">19</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_013">Description of Capital Stock</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">21</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_014">Certain Provisions of New York Law and of Our Charter and Bylaws</a></td>
    <td style="text-align: center">22</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_015">Legal Matters</a></td>
    <td style="text-align: center">24</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_016">Experts</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">24</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_017">Where You Can Find Additional Information</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">24</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_018">Incorporation of Certain Information by Reference</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">25</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_002"></span>About This Prospectus</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement that we have filed with the SEC pursuant to which the Selling Stockholder named herein may, from time to time,
offer and sell or otherwise dispose of the securities covered by this prospectus. You should not assume that the information contained
in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or that any information
we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though
this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider
all information contained in this prospectus, including the Information Incorporated by Reference herein, in making your investment decision.
You should also read and consider the information in the documents to which we have referred you under the captions &#8220;<a href="#s1_017">Where You Can Find More Information</a>&#8221; and &#8220;<a href="#s1_018">Incorporation of Certain Information by Reference</a>&#8221; in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither we nor the Selling
Stockholder have authorized any dealer, salesman or other person to give any information or to make any representation other than those
contained or incorporated by reference in this prospectus. You must not rely upon any information or representation not contained or incorporated
by reference in this prospectus. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any of our
securities other than the securities covered hereby, nor does this prospectus constitute an offer to sell or the solicitation of an offer
to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about,
and to observe, any restrictions as to the offering and the distribution of this prospectus applicable to those jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We further note that the representations,
warranties and covenants made in any agreement that is filed as an exhibit to any document that is incorporated by reference in the accompanying
prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating
risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and
covenants should not be relied on as accurately representing the current state of our affairs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this prospectus
is accurate as of the date on the front cover. Information incorporated by reference into this prospectus is accurate as of the date of
the document from which the information is incorporated. You should not assume that the information contained in this prospectus is accurate
as of any other date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context otherwise
indicates, when used in this prospectus, the terms the &#8220;Company,&#8221; &#8220;Forward,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; and similar terms refer to Forward Industries, Inc., a New York corporation and our subsidiaries Intelligent Product
Solutions, Inc. (&#8220;IPS&#8221;), and Kablooe, Inc. (&#8220;Kablooe&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_003"></span>Cautionary Statement
Regarding Forward-Looking Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus includes forward-looking
statements including, but not limited to, statements regarding our liquidity, anticipated capital expenditures, and expected sales to
the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All statements other than
statements of historical facts contained in this prospectus, including statements regarding our future financial position, liquidity,
business strategy and plans and objectives of management for future operations, are forward-looking statements. The words &#8220;believe,&#8221;
&#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221;
&#8220;plan,&#8221; &#8220;could,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;is likely,&#8221; &#8220;will,&#8221; &#8220;expect&#8221;
and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking
statements largely on our current expectations and projections about future events and financial trends that we believe may affect our
financial condition, results of operations, business strategy and financial needs. These forward-looking statements are subject to a number
of risks, uncertainties and assumptions, including those described in &#8220;<a href="#s1_006">Risk Factors</a>&#8221; and elsewhere in this prospectus and
in our filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>We expressly disclaim any
obligation or undertaking to update or revise any forward-looking statements contained herein to reflect events or circumstances after
the date on which such statements were made or to reflect the occurrence of unanticipated events, except as may be required by applicable
securities laws.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_004"></span>PROSPECTUS SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>This
summary highlights information contained elsewhere in this prospectus or incorporated by reference. It may not contain all of the information
that you should consider before investing in our securities. You should read this entire prospectus carefully, including the &#8220;<a href="#s1_006">Risk
Factors</a>&#8221; section, and the financial statements and related notes included or incorporated by reference herein. This prospectus
includes forward-looking statements that involve risks and uncertainties. See &#8220;<a href="#s1_003">Cautionary Statement Regarding
Forward-Looking Statements</a>.&#8221;</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our company was formed under the
laws of the state of New York in 1961. Our address is 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, and our telephone
number is (631) 547-3055. Our website address is www.forwardindustries.com. Our website and the information contained on, or that can
be accessed through, our website is not deemed to be incorporated by reference into, and does not constitute part of, this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Company </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward is an engineering
design company serving top-tier customers worldwide. The Company provides hardware and software product design and engineering services
to customers predominantly located in the U.S.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide a complete range
of design, engineering and development services with respect to a diverse array of consumer and industrial electronics products. These
include but are not limited to medical products, smart displays, beverage vending, enterprise and mobile software applications, lighting,
security and detections systems, cameras, wearables and vehicle controls. Solutions in these and other areas are designed and developed
in-house, beginning at product concept, extending through design, engineering and prototype, and final design for manufacturing and computer-aided
design files.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The C/M Capital Transaction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, the Company and
C/M Capital entered into the Purchase Agreement which provides that subject to the terms and conditions set forth therein, the Company
may sell to C/M Capital up to $35,000,000 in aggregate gross proceeds from sales of the Company&#8217;s common stock, par value $0.01
per share (the &#8220;Purchase Shares&#8221;) or an amount of shares of common stock not exceeding the Exchange Cap (as defined below).
As consideration for the Selling Stockholder&#8217;s execution and delivery of the Purchase Agreement, we have agreed to issue to the
Selling Stockholder, (i) on the execution date of the Purchase Agreement, an amount of shares of common stock equal to 0.5% of the Available
Amount (as defined in the Purchase Agreement) (24,929 shares) and (ii) <span style="background-color: white">simultaneously with the delivery
of any and all Purchase Shares purchased under the Purchase Agreement, a number of shares of common stock equal to 1% of the number of
Purchase Shares actually sold in each sale under the Purchase Agreement (the &#8220;Commitment Shares&#8221; and, together with the Purchase
Shares, the &#8220;Securities&#8221;).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, on May 16, 2025,
the Company and C/M Capital entered into the Registration Rights Agreement, pursuant to which the Company agreed to file a registration
statement with the SEC covering the resale of shares of common stock that are issued to C/M Capital under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We
do not have a right to commence any sales of common stock to the Selling Stockholder under the Purchase Agreement until the Commencement
Date (as defined in the Purchase Agreement). Over the 36-month period from and after the Commencement Date (unless the Purchase Agreement
is terminated earlier in accordance with its terms), the Selling Stockholder has no right to require us to sell any shares of common stock
to the Selling Stockholder, but subject to the satisfaction of the conditions set forth in the Purchase Agreement, the Selling Stockholder
is obligated to make purchases as we direct in accordance with the terms of the Purchase Agreement. There are no upper limits on the price
per share that the Selling Stockholder must pay for shares of common stock. Actual sales of shares of common stock to the Selling Stockholder
will depend on a variety of factors to be determined by us from time to time, including, among others, market conditions, the trading
price of our common stock and determinations by us as to the appropriate sources of funding for us and our operations</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
any time from and after the Commencement Date, on any business day on which the previous business day&#8217;s closing sale price of common
stock was equal to or greater than $1.00 (the &#8220;Fixed Purchase Date&#8221;), we may direct the Selling Stockholder to purchase a
specified number of shares of common stock (a &#8220;Fixed Purchase&#8221;) not to exceed on any single business day the lesser of (i)
$400,000 of shares of common stock or (ii) 10,000 shares of common stock, at a purchase price equal to the lesser of 95% of (i) the lowest
sale price of the common stock on the trading day immediately prior to such applicable Fixed Purchase Date or (ii) the daily volume weighted
average price (the &#8220;VWAP&#8221;) of the common stock for the five trading days immediately preceding the applicable Fixed Purchase
Date for such Fixed Purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
addition, at any time from and after the Commencement Date, on any business day on which the previous business day&#8217;s closing sale
price of the common stock is equal to or greater than $1.00 and such business day is also the Purchase Date for a Fixed Purchase of an
amount of shares of Common Stock not less than the applicable Fixed Purchase Share Limit (as defined in the Purchase Agreement) (the &#8220;VWAP
Purchase Date&#8221;), we may also direct the Selling Stockholder to purchase an additional number of shares of common stock (a &#8220;VWAP
Purchase&#8221;) at a purchase price equal to the lesser of 95% of (i) the closing price of a share of common stock on the trading day
immediately prior to such applicable VWAP Purchase Date and (ii) the lowest sale price of the common stock on such applicable VWAP Purchase
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
any time from and after the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, we may also
direct the Selling Stockholder to purchase, on such same business day (the &#8220;Additional VWAP Purchase Date&#8221; and</span>, together
with a <span style="background-color: white">Fixed Purchased Date and a VWAP Purchase Date, a &#8220;Purchase Date&#8221;), an additional
number of shares of common stock (an &#8220;Additional VWAP Purchase&#8221; and</span>, together with a <span style="background-color: white">Fixed
Purchase and a VWAP Purchase, a &#8220;Purchase&#8221;) at a purchase price equal to the lesser of 95% of (i) the closing price of a share
of common stock on the business day immediately prior to such applicable Additional VWAP Purchase Date and (ii) the lowest sale price
of the common stock on such applicable Additional VWAP Purchase Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">If
we make certain issuances of our securities within three business days after a Purchase Date and such securities are issued at prices
(the &#8220;New Issuance Price&#8221;) less than the prices to be paid by the Selling Stockholder in such Fixed Purchase, VWAP Purchase
or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase, VWAP Purchase and Additional VWAP Purchase would be
reduced to the New Issuance Price, subject to the terms and conditions set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Under
the Purchase Agreement, in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase
notices and/or Additional VWAP Purchase notices on a particular date require a payment from the Selling Stockholder to us that exceeds
$2,000,000, unless such limitation is waived by the Selling Stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
no event shall we issue or sell any shares of common stock pursuant to the Purchase Agreement to the extent that after giving effect
thereto, the aggregate number of shares of common stock that would be issued pursuant to the Purchase Agreement (including the Commitment
Shares) would exceed 19.99% of the total number of shares of common stock issued and outstanding immediately preceding the execution
of the Purchase Agreement (the &#8220;Exchange Cap&#8221;), subject to adjustment as set forth in the Purchase Agreement, unless and
until (i) we obtain the approval of the issuance of such shares by our stockholders in accordance with the applicable stock exchange
rules or (ii) the average price paid for all shares of common stock issued under the Purchase Agreement (including Commitment Shares)
is equal to or in excess of $7.10 which is the lower of (A) the closing price on the Nasdaq Capital Market on May 15, 2025 and (B) the
average of the closing prices of the common stock for the five business days immediately preceding May 16, 2025, as calculated in accordance
with the rules of the Nasdaq Capital Market, such that the sales of such common stock to the Selling Stockholder would not count toward
the Exchange Cap because they are &#8220;at market&#8221; under applicable stock exchange rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"></span>In addition, the Selling Stockholder
is not obligated to buy any shares of common stock pursuant to the Purchase Agreement if such shares of common stock, when aggregated
with all other common stock then beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section
13(d) of the Securities Exchange Act of 1934, and Rule 13d-3 promulgated thereunder), would result in the Selling Stockholder beneficially
owning common stock in excess of 4.99% of the then-outstanding shares of common stock (the &#8220;Beneficial Ownership Limitation&#8221;),
provided, however, the Selling Stockholder may increase the Beneficial Ownership Limitation up to 9.99% at its sole discretion upon sixty-one
days&#8217; prior written notice to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The net proceeds under the Purchase
Agreement to us will depend on the frequency and prices at which we sell shares of our stock to the Selling Stockholder. We intend to
use the net proceeds for working capital and general corporate purposes. We will retain broad discretion over the use of the net proceeds
from this offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right to terminate
the Purchase Agreement at any time, upon one business days&#8217; notice, at no cost or penalty. During any Suspension Event (as defined
in the Purchase Agreement), while the Selling Stockholder does not have the right to terminate the Purchase Agreement, we may not initiate
any Purchase until such Suspension Event has been cured in accordance with the terms of the Purchase Agreement. In addition, in the event
of bankruptcy proceedings by or against us, the Purchase Agreement will automatically terminate in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are substantial risks to our stockholders as a result of the sale and issuance
of common stock to the Selling Stockholder under the Purchase Agreement, including but not limited to the following: substantial dilution,
significant declines in our stock price and our inability to draw sufficient funds when needed. See
&#8220;<a href="#s1_006">Risk Factors</a>.&#8221; The sale of our common stock to the Selling Stockholder under the Purchase Agreement will not affect the rights
or privileges of our other stockholders, except that the economic and voting interests of our existing stockholders will be diluted as
a result of any such sale. Although the number of shares of common stock that our other stockholders own will not decrease, the shares
owned by our other stockholders will represent a smaller percentage of our total outstanding shares after any such sale to the Selling
Stockholder under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_005"></span>THE OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following summary
contains basic information about this offering. The summary is not intended to be complete. You should read the full text and more
specific details contained elsewhere in this prospectus.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 40%; text-align: justify"><b>Common stock offered by the Selling Stockholder</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 58%; text-align: justify">273,000 shares of our common stock, consisting of (i) up to 245,571
Purchase Shares that may be issued by us to the Selling Stockholder, from time to time at our sole discretion, pursuant to the Purchase
Agreement, and (ii) up to 27,429 Commitment Shares of which 24,929 shares of common stock are outstanding.</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Common stock outstanding immediately prior to this offering</b></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">1,125,998 shares </td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Common stock outstanding immediately following this offering</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">1,374,069 shares</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Terms of the offering</b>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">The Selling Stockholder will determine when and how it will dispose of any
    shares of our common stock that are registered under this prospectus for resale. See &#8220;<a href="#s1_012">Plan of Distribution</a>.&#8221;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Use of proceeds</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">We will not receive any of the proceeds from the sale of shares of our common
stock offered by the Selling Stockholder. Additionally, we will not receive any proceeds from the issuance or sale of any Commitment
Shares. We may receive up to $35,000,000 in aggregate gross proceeds from the Selling Stockholder under the Purchase Agreement in connection
with sales of our shares of our common stock to the Selling Stockholder pursuant to the Purchase Agreement after the date of this prospectus.
However, the actual proceeds may be less than this amount depending on the number of shares of our common stock sold and the price at
which the shares of our common stock are sold. We intend to use of the net proceeds that we receive under the Purchase Agreement for
working capital and other general corporate purposes. However, as of the date of this prospectus, we cannot specify with certainty all
of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. See &#8220;<a href="#s1_008">Use
of Proceeds</a>&#8221; on page 16 of this prospectus.</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Stock Symbol</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">FORD</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Transfer Agent and Registrar</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Equiniti Trust Company, LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The number of shares of our common
stock to be outstanding after this offering assumes 1,125,998 shares of our common stock outstanding as of June 9, 2025, and excludes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 94%; text-align: justify"><span style="font-size: 10pt">132,113 shares of our common stock issuable upon the exercise of options at a weighted-average exercise price of $8.52 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">118,611 shares of our common stock issuable upon the exercise of warrants outstanding as of at an average exercise price of $7.20; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">1,243,000 shares of our common stock available for future issuance under our 2021 Equity Incentive Plan.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless otherwise indicated, all information in this
prospectus assumes no exercise or settlement of outstanding options or warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_006"></span>RISK FACTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves risks. Before purchasing the securities offered by this prospectus you should carefully read the risk factors incorporated by
reference in this prospectus from our Annual Report on Form 10-K for the year ended September 30, 2024 filed with the SEC on December
27, 2024, as well as the risks, uncertainties and additional information set forth in the other documents incorporated by reference in
this prospectus that we file with the SEC after the date of this prospectus and which are deemed incorporated by reference in this
prospectus, and the information contained in any applicable prospectus supplement. For a description of these reports and documents, and
information about where you can find them, see &#8220;<a href="#s1_018">Incorporation of Certain Information by Reference</a>.&#8221; The risks and uncertainties
we discuss in this prospectus and in the documents incorporated by reference in this prospectus are those that we currently believe may
materially affect our company. Additional risks not presently known, or currently deemed immaterial, also could materially and adversely
affect our financial condition, results of operations, business and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="s1_019"></span>Risks Related to the Committed Equity Financing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>It is not possible to predict the actual
number of shares of our common stock, if any, we will sell under the Purchase Agreement, or the actual gross proceeds resulting from those
sales or the dilution to you from those sales. Further, we may not have access to the full amount available under the Purchase Agreement.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Selling Stockholder shall, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to the lesser of (a) $35,000,000 of shares of common stock and (b) the Exchange Cap, upon the terms and subject to the conditions
and limitations set forth in the Purchase Agreement (such amount, the &#8220;Commitment Amount&#8221;); provided, however, that such limitations
will not apply if we obtain stockholder approval to issue additional shares of common stock and, accordingly, we have registered 273,000
shares for issuance under the Purchase Agreement and resale pursuant to this prospectus, assuming that such stockholder approval is obtained.
The shares of our common stock that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction
of the conditions in the Purchase Agreement, by us to the Selling Stockholder at our discretion from time to time from the Commencement
Date (as defined below) until the earliest to occur of (i) the first day of the month next following the 36-month anniversary of the Commencement
Date, (ii) the date on which the Selling Stockholder shall have purchased the Commitment Amount, and (iii) the Purchase Agreement is otherwise
terminated in accordance with its terms.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have a right to
commence any sales of common stock to the Selling Stockholder under the Purchase Agreement until the time when all of the conditions to
our right to commence sales of common stock to the Selling Stockholder set forth in the Purchase Agreement have been satisfied, or the
Commencement Date, including the effectiveness of the registration statement of which this prospectus forms a part. Over the 36-month
period from and after the Commencement Date, we will generally have the right to control the timing and amount of any sales of our common
stock to the Selling Stockholder under the Purchase Agreement. Sales of our common stock, if any, to the Selling Stockholder under the
Purchase Agreement will depend upon market conditions, our capital needs, alternative financing options, and other factors to be determined
by us in our sole discretion. We may ultimately decide to sell to the Selling Stockholder all, some or none of the common stock that may
be available for us to sell to the Selling Stockholder pursuant to the Purchase Agreement. Accordingly, we cannot guarantee that we will
be able to sell all of the Commitment Amount or how much in proceeds we may obtain under the Purchase Agreement. If we cannot sell securities
under the Committed Equity Financing, we may be required to utilize more costly and time-consuming means of accessing the capital markets,
which could have a material adverse effect on our liquidity and cash position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the purchase price
per share of common stock to be paid by the Selling Stockholder for the common stock that we may elect to sell to the Selling Stockholder
under the Purchase Agreement, if any, will fluctuate based on the market prices of our common stock at the time we make such election,
it is not possible for us to predict, as of the date of this prospectus and prior to any such sales, the number of shares of common stock
that we will sell to the Selling Stockholder under the Purchase Agreement, the purchase price per share that the Selling Stockholder will
pay for shares of common stock purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from
those purchases the Selling Stockholder under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We
                                            are registering 273,000 shares of our common stock under this prospectus. As of June 9,
                                            2025, there were 1,125,998 shares of common stock outstanding. If all of the 273,000 shares
                                            of our common stock offered for resale by the Selling Stockholder under this prospectus were
                                            issued and outstanding as of June 9, 2025, such shares would represent approximately
                                            19.9% of total number of shares of our common stock outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The actual number of shares of
our common stock issuable will vary depending on the then current market price of shares of our common stock sold to the Selling Stockholder
in this offering and the number of shares of our common stock we ultimately elect to sell to the Selling Stockholder under the Purchase
Agreement. If it becomes necessary for us to issue and sell to the Selling Stockholder under the Purchase Agreement more than the amount
of purchase shares being registered for resale under this prospectus in order to receive aggregate gross proceeds equal to $35,000,000
under the Purchase Agreement, we must file with the SEC one or more additional registration statements to register under the Securities
Act the resale by the Selling Stockholder of any such additional shares of our common stock we wish to sell from time to time under the
Purchase Agreement, which the SEC must declare effective, in each case before we may elect to sell any additional shares of our common
stock under the Purchase Agreement. Under applicable Nasdaq rules, in no event may we issue to the Selling Stockholder shares of our common
stock representing more than 19.99% of the total number of shares of common stock outstanding immediately prior to the execution of the
Purchase Agreement, or approximately 220,000 shares of common stock, unless (i) we obtain the approval of the issuance of additional shares
by our stockholders in accordance with the applicable stock exchange rules or (ii) the average price paid for all shares of common stock
issued under the Purchase Agreement (including both Purchase Shares and Commitment Shares) is equal to or greater than $7.10, which is
a price equal to the lower of (A) the Nasdaq Official Closing Price immediately preceding the execution of the Purchase Agreement and
(B) the average Nasdaq Official Closing Price of our common stock for the five trading days immediately preceding the execution of the
Purchase Agreement, as calculated in accordance with the rules of Nasdaq, such that the sales of such common stock to the Selling Stockholder
would not count toward such limit because they are &#8220;at market&#8221; under applicable stock exchange rules.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Selling Stockholder
is not obligated to buy any common stock under the Purchase Agreement if such shares, when aggregated with all other common stock then
beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act,
and Rule 13d-3 promulgated thereunder), would result in the Selling Stockholder beneficially owning common stock in excess of 4.99% of
the then-outstanding shares of common stock, or the Beneficial Ownership Limitation; provided, however, the Selling Stockholder may increase
the Beneficial Ownership Limitation up to 9.99% at its sole discretion upon sixty-one days&#8217; prior written notice to us. Our inability
to access a portion or the full amount available under the Purchase Agreement, in the absence of any other financing sources, could have
a material adverse effect on our business or results of operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Selling Stockholder will pay less than
the then-prevailing market price for our common stock, which could cause the price of our common stock to decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price of our
common stock to be sold to the Selling Stockholder under the Purchase Agreement is derived from the market price of our common stock on
Nasdaq. Shares to be sold to the Selling Stockholder pursuant to the Purchase Agreement will be purchased at a discounted price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For example, we may effect
sales to the Selling Stockholder pursuant to a Fixed Purchase Notice  at a purchase price equal to the lesser of 95%
of (i) the lowest sale price of a share of common stock on the business day immediately preceding the applicable Fixed Purchase Date and
(ii) the daily volume weighted average price of the common stock for the five trading days immediately preceding the applicable Fixed
Purchase Date. This pricing mechanism means that shares will always be sold at a 5% or greater discount to market price. See &#8220;<a href="#s1_007">The Committed Equity Financing</a>&#8221; for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of this pricing
structure, the Selling Stockholder may sell the shares they receive immediately after receipt of such shares, which could cause the price
of our common stock to decrease. This immediate resale could create downward pressure on our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="s1_020"></span>Investors who buy shares of common stock
from the Selling Stockholder at different times will likely pay different prices.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
we have discretion (subject to the restrictions and satisfaction of the conditions in the Purchase Agreement) to vary the timing, price
and number of shares of common stock we sell to the Selling Stockholder. If and when we elect to sell shares of common stock to the Selling
Stockholder pursuant to the Purchase Agreement, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell
all, some or none of such shares at any time or from time to time in its sole discretion and at different prices. As a result, investors
who purchase shares from the Selling Stockholder in this offering at different times will likely pay different prices for those shares,
and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
Investors may experience a decline in the value of the shares they purchase from the Selling Stockholder in this offering as a result
of future sales made by us to the Selling Stockholder at prices lower than the prices such investors paid for their shares in this offering.
In addition, if we sell a substantial number of shares to the Selling Stockholder under the Purchase Agreement, or if investors expect
that we will do so, the actual sales of shares or the mere existence of our arrangements with the Selling Stockholder may make it more
difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect
such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future resales and/or issuances of shares
of common stock, including pursuant to this prospectus, or the perception that such sales may occur, may cause the market price of our
shares to drop significantly.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, we entered
into the Purchase Agreement, pursuant to which the Selling Stockholder shall, subject to the restrictions and satisfaction of the conditions
in the Purchase Agreement, purchase from us up to an aggregate of $35,000,000 of shares of common stock, upon the terms and subject to
the conditions and limitations set forth in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of our common stock
that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction of the conditions in the Purchase
Agreement, by us to the Selling Stockholder at our discretion from time to time from the date of effectiveness of the registration statement
of which this prospectus forms a part until the earliest to occur of (i) the first day of the month next following the 36-month anniversary
of the Commencement Date, (ii) the date on which the Selling Stockholder shall have purchased the Commitment Amount, or (iii) the Purchase
Agreement is otherwise terminated in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price for shares
of our common stock that we may sell to the Selling Stockholder under the Purchase Agreement will fluctuate based on the trading price
of shares of our common stock. Depending on market liquidity at the time, sales of shares of our common stock may cause the trading price
of shares of our common stock to decrease. We generally have the right to control the timing and amount of any future sales of shares
of our common stock to the Selling Stockholder. Additional sales of shares of our common stock, if any, to the Selling Stockholder will
depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to the Selling Stockholder all,
some or none of the additional shares of our common stock that may be available for us to sell pursuant to the Purchase Agreement. If
and when we do sell shares of our common stock to the Selling Stockholder, after the Selling Stockholder has acquired shares of our common
stock, the Selling Stockholder may resell all, some, or none of such shares of our common stock at any time or from time to time in its
discretion and at different prices. Therefore, sales to the Selling Stockholder by us could result in substantial dilution to the interests
of other holders of shares of our common stock. In addition, if we sell a substantial number of shares of our common stock to the Selling
Stockholder under the Purchase Agreement, or if investors expect that we will do so, the shares held by the Selling Stockholder will represent
a significant portion of our public float and may result in substantial decreases to the price of our common stock. The actual sales of
shares of our common stock or the mere existence of our arrangement with the Selling Stockholder may also make it more difficult for us
to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to affect such sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, shares of our
common stock issuable upon exercise or vesting of incentive awards under our incentive plans are, once issued, eligible for sale in the
public market, subject to any lock-up agreements and, in some cases, limitations on volume and manner of sale applicable to affiliates
under Rule 144. Furthermore, shares of our common stock reserved for future issuance under our incentive plan may become available for
sale in future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may use proceeds from sales of our common
stock made pursuant to the Purchase Agreement in ways with which you may not agree or in ways which may not yield a significant return.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will have broad discretion
over the use of proceeds from sales of our common stock made pursuant to the Purchase Agreement, including for any of the purposes described
in the section entitled &#8220;<a href="#s1_008">Use of Proceeds</a>,&#8221; and you will not have the opportunity, as part of your investment decision, to
assess whether the proceeds are being used appropriately. Because of the number and variability of factors that will determine our use
of the net proceeds, their ultimate use may vary substantially from their currently intended use. While we expect to use the net proceeds
from this offering as set forth in &#8220;<a href="#s1_008">Use of Proceeds</a>,&#8221; we are not obligated to do so. The failure by us to apply these funds
effectively could harm our business, and the net proceeds may be used for corporate purposes that do not increase our operating results
or enhance the value of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Financial Position and
Capital Needs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>If we do not raise
debt or equity capital, we may not be able to pay all of our contractual obligations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The extent
we rely on the Selling Stockholder as a source of funding will depend on a number of factors including, the prevailing market price of
our common stock and volume of trading and the extent to which we are able to secure working capital from other sources. If obtaining
sufficient funding from the Selling Stockholder does not occur for any reason including the Selling Stockholder suffering liquidity issues
or failure of the Company to keep the registration statement current, we will need to secure another source of funding in order to pay
off our contractual obligations. Should the financing we require be unavailable or prohibitively expensive when we require it, such circumstances
would likely have a material adverse effect on our business, operating results, financial condition and prospects.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our auditors have issued a &#8220;going
concern&#8221; audit opinion.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our independent auditors have
indicated in their report on our September 30, 2024 and September 30, 2023 financial statements that there is substantial doubt about
our ability to continue as a going concern. A &#8220;going concern&#8221; opinion indicates that the financial statements have been prepared
assuming we will continue as a going concern for one year from the date the financial statements are issued and do not include any adjustments
to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities
that may result if we do not continue as a going concern. Therefore, you should not rely on our balance sheet as an indication of the
amount of proceeds that would be available to satisfy claims of creditors, and potentially be available for distribution to stockholders,
in the event of liquidation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to factors beyond our control, our stock
price may be volatile.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of the following factors
could affect the market price of our common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 9%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 88%">Our failure to increase revenue in each succeeding quarter and achieve and thereafter maintain profitability;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our failure to meet our revenue and earnings guidance or our failure to meet financial analysts&#8217;
performance expectations;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Cybersecurity breaches;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The loss of customers or our failure to attract more customers;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Creditworthiness and solvency of clients;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Loss of key employees;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The sale of a large amount of common stock by our stockholders;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our announcement of a pending or completed acquisition or our failure to complete a proposed acquisition;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">An adverse court ruling or regulatory action;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Changes in regulatory practices, including tariffs and taxes;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Changes in market valuations of similar companies;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Short selling activities;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our announcement of any financing or a change in the direction of our business;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Announcements by us, or our competitors, of significant contracts, acquisitions, commercial relationships,
joint ventures or capital commitments; or</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Other forces outside of our control such as inflation, Federal Reserve interest rate increases and the
recessionary environment it could bring, geopolitical turmoil and other developments that could adversely impact the U.S. and global economies
and erode investor sentiment.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the past, following periods
of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been instituted. A securities
class action suit against us could result in substantial costs and divert our management&#8217;s time and attention, which would otherwise
be used to benefit our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_007"></span>THE COMMITTED EQUITY FINANCING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, we entered
into the Purchase Agreement with the Selling Stockholder. Sales of our common stock to the Selling Stockholder under the Purchase Agreement,
and the timing of any sales, will be determined by us from time to time in our sole discretion and will depend on a variety of factors,
including, among other things, market conditions, the trading price of our common stock and determinations by us regarding the use of
proceeds from any sale of such common stock. The net proceeds from any sales under the Committed Equity Financing will depend on the frequency
with, and prices at which, the shares of common stock are sold to the Selling Stockholder. To the extent we sell shares under the Purchase
Agreement, we currently plan to use the net proceeds for working capital and other general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with our obligations
under the Purchase Agreement, or the Registration Rights Agreement, pursuant to which we agreed to provide the Selling Stockholder with
customary registration rights related to the shares issued under the Purchase Agreement, we have filed a registration statement of which
this prospectus forms a part in order to register the resale of up to: (i) 245,571 Purchase Shares that we may elect, in our sole discretion,
to issue and sell to the Selling Stockholder, from time to time after the Commencement Date upon the terms and subject to the conditions
and limitations of the Purchase Agreement, subject to applicable stock exchange rules; and (ii) 2,500 Commitment Shares that may be issued
to the Selling Stockholder in connection with related issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s
execution and delivery of the Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable Nasdaq rules,
in no event may we issue to the Selling Stockholder shares of our common stock representing more than 19.99% of the total number of shares
of common stock outstanding immediately prior to the date of the Purchase Agreement, unless we obtain prior stockholder approval or if
such approval is not required in accordance with the applicable Nasdaq rules. In addition, the Selling Stockholder is not obligated to
buy any common stock under the Purchase Agreement if such shares, when aggregated with all other common stock then beneficially owned
by the Selling Stockholder and its respective affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated
thereunder), would result in the Selling Stockholder beneficially owning common stock in excess of 4.99% of the then-outstanding shares
of common stock, or the Beneficial Ownership Limitation; provided, however, the Selling Stockholder may increase the Beneficial Ownership
Limitation up to 9.99% at its sole discretion upon sixty-one days&#8217; prior written notice to us. Our inability to access a portion
or the full amount available under the Purchase Agreement, in the absence of any other financing sources, could have a material adverse
effect on our business or results of operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement and
Registration Rights Agreement contain customary registration rights, representations, warranties, conditions and indemnification obligations
by each party. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements
and as of specific dates, were solely for the benefit of the parties to such agreements and are subject to certain important limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Selling Stockholder shall subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to the lesser of (i) $35,000,000 in aggregate value of shares of our common stock and (ii) the Exchange Cap, upon the terms and
subject to the conditions and limitations set forth in the Purchase Agreement, or the Commitment Amount; provided, however, that such
limitations will not apply if we obtain stockholder approval to issue additional shares of common stock. The shares of our common stock
that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction of the conditions in the Purchase
Agreement, by us to the Selling Stockholder at our discretion from time to time from the Commencement Date until the earliest to occur
of (i) the first day of the month next following the 36-month anniversary of the Commencement Date, (ii) the date on which the Selling
Stockholder shall have purchased the Commitment Amount, (iii) the ninetieth day after the date on which, pursuant to or within the meaning
of any bankruptcy law, we commence a voluntary case or any person commences a proceeding against us, in each case that is not discharged
or dismissed prior to such ninetieth day, and (iv) the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian
is appointed for us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors,
or each, a Termination Event.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Purchases of Shares of Our Common Stock Under
the Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the term described above,
on any business day on which the closing sale price of the common stock on Nasdaq is equal to or greater than $1.00, we will have the
right, but not the obligation, from time to time at our sole discretion, subject to the restrictions and satisfaction of the conditions
in the Purchase Agreement, to direct the Selling Stockholder, by delivery of an irrevocable written notice (a &#8220;Fixed Purchase Notice&#8221;),
to purchase a number of shares of our common stock, or the Fixed Purchase, not to exceed, on any trading day, the lesser of (i) $400,000
worth of shares of Common Stock or (ii) 10,000 shares of Common Stock, at a purchase price equal to the lesser of 95% <span style="background-color: white">(i)
lowest sale price of the common stock on the trading day immediately prior to such applicable Fixed Purchase Date or (ii) the daily VWAP
of the common stock for the five trading days immediately preceding the applicable Purchase Date for such Fixed Purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, at any time from
and after the Commencement Date, on any business day on which the closing sale price of the common stock is equal to or greater than $1.00
and such business day is also the Fixed Purchase Date for a Fixed Purchase of an amount of shares of common stock not less than the applicable
<span style="background-color: white">Fixed Purchase Share Limit</span> (calculated as of the applicable Fixed Purchase Date), we may
also direct the Selling Stockholder, by delivery of a VWAP Purchase Notice, to purchase, on the immediately following business day (the
&#8220;VWAP Purchase Date&#8221;), an additional number of shares of common stock in an amount not in excess of the lesser of (i) 300%
of the number of shares of common stock directed by us to be purchased by the Selling Stockholder for the applicable Fixed Purchase and
(ii) 30% of the trading volume in our common stock on Nasdaq during the applicable VWAP Purchase Period on the applicable VWAP Purchase
Date, at a purchase price equal to the lesser of 95% of (i) the closing sale price of the common stock on the business day immediately
preceding the applicable VWAP Purchase Date and (ii) the lowest sale price of the common stock during the applicable VWAP Purchase Period.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time from and after
the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, we may also direct the Selling Stockholder,
by delivery of an irrevocable written notice, (an &#8220;Additional VWAP Purchase Notice&#8221; and, together with a Fixed Purchase Notice
and a VWAP Purchase Notice, a &#8220;Purchase Notice&#8221;), to purchase, on the same business day (the &#8220;Additional VWAP Purchase
Date&#8221; and, together with a Fixed Purchase Date and a VWAP Purchase Date, the &#8220;Purchase Dates&#8221;), an additional number
of shares of common stock in an amount equal to the lesser of (i) 300% of the number of shares of common stock directed by us to be purchased
by the Selling Stockholder pursuant to the corresponding Fixed Purchase and (ii) 30% of the trading volume in our common stock on Nasdaq
during the applicable Additional VWAP Purchase Period on the applicable Additional VWAP Purchase Date, at a purchase price equal to the
lesser of 95% of (i) the closing sale price of the common stock on the business day immediately preceding the applicable Additional VWAP
Purchase Date and (ii) the lowest sale price of the common stock during the applicable Additional VWAP Purchase Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the above,
in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase notices and/or Additional
VWAP Purchase notices on a particular date require a payment from the Selling Stockholder to us that exceeds $2,000,000, unless such limitation
is waived by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the Purchase
Agreement, &#8220;VWAP&#8221; shall mean the daily volume weighted average price of the common stock on Nasdaq as reported by Bloomberg
through its &#8220;AQR&#8221; function.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All such determinations shall
be appropriately adjusted for any sales of shares of common stock through block transactions, any reorganization, non-cash dividend, stock
split, reverse stock split, stock combination, recapitalization or other similar transaction during such period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Commitment Shares and Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with entering
into the ELOC Agreement, the Company agreed to immediately issue to the Purchaser, 24,929 shares of common stock as commitment shares
and, thereafter an amount of shares equal to 1% of the Available Amount, which shall be issued in a pro rated fashion simultaneously with
the delivery of any and all Purchase Shares purchased under the ELOC Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have paid the Selling Stockholder
$25,000 in cash as reimbursement for the reasonable, out-of-pocket expenses incurred by the Selling Stockholder, including the legal fees
and disbursements of the Selling Stockholder&#8217;s legal counsel, in connection with its due diligence investigation and the preparation,
negotiation and execution of the Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conditions Precedent to Commencement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our right to commence delivering
Purchase Notices under the Purchase Agreement and the Selling Stockholder&#8217;s obligation to accept such Purchase Notices, are subject
to the initial satisfaction, at the Commencement Date, of the conditions precedent thereto set forth in the Purchase Agreement, which
conditions include, among others, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%">the accuracy in all material respects of our representations and warranties included in the Purchase Agreement;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">this prospectus, in final form, and all reports, schedules, registrations, forms, statements, information
and other documents required to have been filed by us with the SEC pursuant to the reporting requirements of the Exchange Act having been
so filed;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the common stock not having been suspended by the SEC, Nasdaq or FINRA and there not having been imposed
any suspension of, or restriction on, accepting additional deposits of common stock by The Depository Trust Company;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in
the Purchase Agreement) shall have occurred and be continuing;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">customary compliance with laws and bankruptcy-related conditions; and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the receipt by the Selling Stockholder of a customary legal opinion, as required under the Purchase Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of the Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless earlier terminated as provided in the Purchase
Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%">the first day of the month immediately following the 36-month anniversary of the Commencement Date;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the date on which the Selling Stockholder shall have purchased the Commitment Amount;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the ninetieth day after the date on which, pursuant to or within the meaning of any bankruptcy law, we
commence a voluntary case or any person commences a proceeding against us, in each case that is not discharged or dismissed prior to such
ninetieth day; and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian is appointed for
us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right to terminate
the Purchase Agreement at any time after the Commencement Date, at no cost or penalty, upon one business day&#8217;s prior written notice
to the Selling Stockholder, provided that we have satisfied all outstanding payment and delivery obligations related to any Purchase Shares
issued to the Selling Stockholder prior to the effective date of such termination. We or the Selling Stockholder may also terminate the
Purchase Agreement at the close of business on the one year anniversary of the signing of the Purchase Agreement or thereafter, in the
event the Commencement Date shall not have occurred prior to such one year anniversary due to our failure to satisfy the conditions precedent
to commencement. We and the Selling Stockholder may also terminate the Purchase Agreement at any time by mutual written consent. No termination
of the Purchase Agreement by us or by the Selling Stockholder will affect any of our respective rights and obligations under (i) the Purchase
Agreement with respect to any pending Purchase, and both we and the Selling Stockholder have agreed to complete our respective obligations
with respect to any such pending Purchase under the Purchase Agreement, and (ii) the Registration Rights Agreement, which shall survive
any termination of the Purchase Agreement. Further, no termination of the Purchase Agreement will be deemed to release us or the Selling
Stockholder from any liability for intentional misrepresentation or willful breach of the Purchase Agreement, the Registration Rights
Agreement or any other related transaction documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Dilutive Issuances and Purchase Price Adjustment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For as long as the Selling
Stockholder owns any of our common stock, if within three business days immediately following a Purchase Date, we issue securities at
prices (the &#8220;New Issuance Price&#8221;) less than the prices to be paid by the Selling Stockholder in such Fixed Purchase, VWAP
Purchase or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase, VWAP Purchase or Additional VWAP Purchase
would be reduced to the New Issuance Price, subject to the terms and conditions set forth in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Short-Selling or Hedging</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
agreed that neither it nor any entity managed or controlled by it will engage in, directly or indirectly, any (A) &#8220;short sale&#8221;
(as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock or (B) hedging transaction, which, with
respect to items (A) and (B), establishes a net short position with respect to the common stock, during the term of the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of Sales of our Common Stock under
the Purchase Agreement on Our Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being registered
for resale in this offering may be issued and sold by us to the Selling Stockholder from time to time at our discretion, during the terms
described above. The resale by the Selling Stockholder of a significant quantity of shares registered for resale in this offering at any
given time, or the perception that these sales may occur, could cause the market price of our common stock to decline and to be highly
volatile. Sales of our common stock, if any, to the Selling Stockholder under the Purchase Agreement will be determined by us in our sole
discretion, subject to the satisfaction of certain conditions in the Purchase Agreement, and will depend upon market conditions and other
factors. We may ultimately decide to sell to the Selling Stockholder all, some or none of the common stock that may be available for us
to sell to the Selling Stockholder pursuant to the Purchase Agreement. If we elect to sell common stock to the Selling Stockholder pursuant
to the Purchase Agreement, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell all, some or none
of such common stock at any time or from time to time in its discretion and at different prices. As a result, investors who purchase common
stock from the Selling Stockholder in this offering at different times will likely pay different prices for those shares of common stock,
and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
See &#8220;<i><a href="#s1_020">Risk Factors-Risks Related to the Committed Equity Financings-Investors who buy shares of common stock from the Selling Stockholder at different times will likely pay different prices</a></i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors may experience a
decline in the value of the common stock they purchase from the Selling Stockholder in this offering as a result of future sales made
by us to the Selling Stockholder at prices lower than the prices such investors paid for their shares in this offering. In addition, if
we sell a substantial number of shares of common stock to the Selling Stockholder under the Purchase Agreement, or if investors expect
that we will do so, the actual sales of common stock or the mere existence of our arrangement with the Selling Stockholder may make it
more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish
to effect such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the purchase price
per share to be paid by the Selling Stockholder for the common stock that we may elect to sell to the Selling Stockholder under the Purchase
Agreement, if any, will fluctuate based on the market prices of our common stock at the time we make such election, as of the date of
this prospectus, it is not possible for us to predict the number of shares of common stock that we will sell to the Selling Stockholder
under the Purchase Agreement, the actual purchase price per share to be paid by the Selling Stockholder for those shares of common stock,
or the actual gross proceeds to be raised by us from those sales, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b>The number of
shares of common stock ultimately offered for sale by the Selling Stockholder for resale under this prospectus is dependent upon the number
of shares of common stock, if any, we ultimately sell to the Selling Stockholder under the Purchase Agreement. Further, if and when we
elect to sell shares of common stock to the Selling Stockholder pursuant to the Purchase Agreement, after the Selling Stockholder has
acquired such shares, the Selling Stockholder may resell all, some, or none of such shares of common stock at any time or from time to
time in its discretion and at different prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of our shares
of common stock to the Selling Stockholder pursuant to the Purchase Agreement will not affect the rights or privileges of our existing
stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number
of shares of common stock that our existing stockholders own will not decrease, the shares of common stock owned by our existing stockholders
will represent a smaller percentage of our total outstanding shares of common stock after any such issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the amount of gross proceeds we may receive from the Selling Stockholder from our sale of Purchase Shares that we may issue and sell to
the Selling Stockholder from time to time under the Purchase Agreement at various assumed purchase prices. The table does not give effect
to the issuance of any Commitment Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Assumed Purchase</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Price Per Share</p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Total Number<br/>
of Purchase Shares<br/>
to be Issued</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Percentage of<br/>
Outstanding Common Stock After Giving Effect<br/>
to the Issuance of<br/>
the Purchase Shares to the Selling Stockholder (1)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Proceeds from the Sale of the Purchase Shares to the Selling Stockholder</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-size: 10pt">1.00</span></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 19%; text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,227,855</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">6.47 </span></td>
    <td><span style="font-size: 10pt">&#160;(2)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,588,844</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">7.10</span></td>
    <td><span style="font-size: 10pt">&#160;(3)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,743,554</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">8.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,964,568</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">9.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">2,210,139</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">10.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">2,455,710</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">__________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; width: 94%"><span style="font-size: 10pt">The denominator is based on 1,371,569 shares of our common
stock outstanding as of June 9, 2025, adjusted to include the issuance of the number of Purchase Shares set forth in the adjacent column
which we would have issued to the Selling Stockholder based on the applicable assumed purchase price per share.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents the last reported sales price of our common stock on June
9, 2025, as reported by Nasdaq.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents the minimum price for which the average price paid for all shares of common stock issued under the Purchase Agreement must be in order for the sales to be considered &#8220;at market&#8221; under applicable stock exchange rules and therefore not subject to the Exchange Cap.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_008"></span>USE OF PROCEEDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We will not receive any of the
proceeds from the sale of shares of our common stock offered by the Selling Stockholder. In addition, we will not receive any proceeds
from the issuance or sale of the Commitment Shares. We may receive up to $35,000,000 in aggregate gross proceeds from sales of shares
of our common stock to the Selling Stockholder pursuant to the Purchase Agreement after the date of this prospectus. However, the actual
proceeds may be less than this amount depending on the number of shares of our common stock sold and the price at which the shares of
our common stock are sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We intend to use the proceeds
for working capital and other general corporate purposes. Our expected use of the net proceeds from this offering represents our intentions
based upon our current plans and business conditions. As of the date of this prospectus, we cannot predict with certainty all of the particular
uses for the net proceeds from this offering or the specific amounts to be spent on the uses described above. As a result, our management
will retain broad discretion over the allocation of the net proceeds from this offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pending the uses described
above, we plan to invest the net proceeds from this offering in short-term, interest-bearing obligations, investment-grade instruments
or other securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_009"></span>MARKET INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 9, 2025, the last
reported sale price of our common stock on Nasdaq was $6.47 per share. As of June 9, 2025, we had approximately 40 stockholders of record.
The actual number of holders of our common stock is greater than this number of record holders and includes stockholders who are beneficial
owners, but whose shares are held in street name by brokers or held by other nominees. This number of holders of record also does not
include stockholders whose shares may be held in trust by other entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_010"></span>DIVIDEND POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not expect to pay any
cash dividends to our stockholders in the foreseeable future. Payment of future cash dividends, if any, will be at the discretion of our
board of directors and will depend on a number of factors, including our results of operations, financial condition, future prospects,
contractual restrictions, restrictions imposed by applicable law, and other factors our board of directors deems relevant<b>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_011"></span>THE SELLING STOCKHOLDER</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus relates to the
possible resale from time to time by the Selling Stockholder of any or all shares of our common stock that have been or may be issued
by us to the Selling Stockholder under the Purchase Agreement. Such shares of our common stock include (i) up to 245,571 Purchase Shares
that we may elect, in our sole discretion, to issue and sell to the Selling Stockholder, from time to time from and after the Commencement
Date under the Purchase Agreement; and (ii) up to 2,500 Commitment Shares that may be issued to the Selling Stockholder in connection
with related issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s execution and delivery of the
Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the term &#8220;Selling Stockholder&#8221; includes the Selling Stockholder listed in the table below, and its permitted pledgees, donees,
transferees, assignees, successors, designees, successors-in-interest and others who later come to hold any of the Selling Stockholder&#8217;s
interest in the shares of common stock in accordance with the terms of the applicable agreements governing their respective registration
rights, other than through a public sale. This prospectus also covers any additional securities that may become issuable by reason of
stock splits, stock dividends or other similar transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For additional
information regarding the issuance of common stock covered by this prospectus, see the section entitled &#8220;<i><a href="#s1_007">Committed
Equity Financing</a>&#8221;</i> above. We are registering the shares of common stock pursuant to the provisions of the Purchase Agreement
and the Registration Rights Agreement in order to permit the Selling Stockholder to offer the shares for resale from time to time.
Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement, the Selling Stockholder
has not had any material relationship with us within the past three years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The
table below presents information regarding the Selling Stockholder and the shares of common stock that it may offer from time to time
under this prospectus. This table is prepared based on information supplied to us by the selling stockholder, and reflects holdings as
of June 9, 2025. The number of shares in the column &#8220;Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus&#8221;
represents all of the shares of common stock that the Selling Stockholder may offer under this prospectus. The Selling Stockholder may
sell some, all or none of its shares in this offering. We do not know how long the Selling Stockholder will hold the shares before selling
them, and we currently have no agreements, arrangements or understandings with the Selling Stockholder regarding the sale of any of the
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is determined
in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of common stock with respect to which
the Selling Stockholder has voting and investment power. The percentage of common stock beneficially owned by the Selling Stockholder
prior to the offering shown in the table below is based on an aggregate of 1,125,998 shares of our common stock outstanding on June 9,
2025. Because the purchase price of the common stock issuable under the Purchase Agreement is determined on each Fixed Purchase Date,
with respect to a Fixed Purchase, on the applicable VWAP Purchase Date, with respect to a VWAP Purchase, and on the applicable Additional
VWAP Purchase Date, with respect to an Additional VWAP Purchase, the number of shares that may actually be sold by us to the Selling
Stockholder under the Purchase Agreement may be fewer than the number of shares being offered by this prospectus. The fourth column assumes
the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may amend or supplement
this prospectus from time to time in the future to update or change the Selling Stockholder list and the securities that may be resold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see the section titled
&#8220;<i><a href="#s1_012">Plan of Distribution</a></i>&#8221; for further information regarding the Selling Stockholder&#8217;s method of distributing these
securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name of Selling Stockholder</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares of<br/> Common Stock Owned<br/> Prior to Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> of Common Stock Owned After Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number <span style="font-size: 10pt">(1)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Percent<span style="font-size: 10pt"> (2)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number <span style="font-size: 10pt">(3)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Percent<span style="font-size: 10pt"> (4)</span></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 25%; text-align: center">C/M Capital Master Fund, LP (4)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">24,929</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">2.2%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">273,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt; width: 5%">(1)</td>
    <td style="text-align: justify; font-size: 10pt; width: 95%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">In accordance with Rule 13d-3(d) under the Exchange Act, we
                                                            have excluded from the number of shares beneficially owned prior to the offering all of the shares that the Selling Stockholder may
                                                            be required to purchase under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject
                                                            to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of the Selling Stockholder&#8217;s
                                                            control, including the registration statement that includes this prospectus becoming and remaining effective. Furthermore, the Fixed
                                                            Purchases, VWAP Purchase, or Additional VWAP Purchase, as applicable, of common stock is subject to certain agreed upon maximum
                                                            amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any of
                                                            our common stock to the Selling Stockholder to the extent such shares, when aggregated with all other common stock then beneficially
                                                            owned by the Selling Stockholder, would cause the Selling Stockholder beneficial ownership of our common stock to exceed the
                                                            Beneficial Ownership Limitation (as defined in the Purchase Agreement)</p>
</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(2)</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">Applicable
percentage ownership is based on 1,125,998<span style="font-family: Times New Roman, Times, Serif">&#160;</span>shares of our common
stock outstanding as of June 9, 2025.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(3)</td>
    <td style="text-align: justify; font-size: 10pt">Assumes the sale of all shares being offered pursuant to this prospectus.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(4)</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">The
    business address of C/M Capital Master Fund, LP is 1111 Brickell Avenue, Suite 2920, Miami, Florida 33131. As of the date of the
    Purchase Agreement, C/M Capital Master Fund, LP did not beneficially own any shares of our common stock. Thomas Walsh and Jonathan
    Juchno are the Managing Partners of C/M Capital Master Fund, LP, and therefore may be deemed to have shared voting and investment
    power over securities owned directly and indirectly by C/M Capital Master Fund, LP. C/M Capital Master Fund, LP is not a registered
    broker-dealer or an affiliate of a registered broker-dealer. The foregoing should not be construed in and of itself as an admission
    by Mr. Walsh and Mr. Juchno as to beneficial ownership of the securities beneficially owned directly or indirectly by C/M Capital
    Master Fund, LP. Does not include shares of common stock issuable under Series B Preferred Stock beneficially owned by C/M Capital.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_012"></span>Plan of Distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of common stock
offered by this prospectus are being offered by the Selling Stockholder. The shares may be sold or distributed from time to time by the
Selling Stockholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market
prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which
may be changed. The sale of our common stock offered by this prospectus could be effected in one or more of the following methods:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokers&#8217;
transactions;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions involving
cross or block trades;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through brokers, dealers,
or underwriters who may act solely as agents;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;at the market&#8221;
into an existing market for our common stock;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in other ways
not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in privately negotiated
transactions; or</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any combination of the
foregoing.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state&#8217;s registration or qualification requirement is available and complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder may be
deemed to be an &#8220;underwriter&#8221; within the meaning of Section 2(a)(11) of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our common stock that it
has acquired and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms
then prevailing or at prices related to the then current market price. Each such registered broker-dealer will be an underwriter within
the meaning of Section 2(a)(11) of the Securities Act. The Selling Stockholder has informed us that each such broker-dealer will receive
commissions from the Selling Stockholder that will not exceed customary brokerage commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers, dealers, underwriters
or agents participating in the distribution of our common stock offered by this prospectus may receive compensation in the form of commissions,
discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the Selling Stockholder
through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of our common stock sold by
the selling stockholder may be less than or in excess of customary commissions. Neither we nor the Selling Stockholder can presently estimate
the amount of compensation that any agent will receive from any purchasers of our common stock sold by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We know of no existing arrangements
between the Selling Stockholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of
our common stock offered by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the Selling Stockholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the Selling Stockholder,
any compensation paid by the Selling Stockholder to any such brokers, dealers, underwriters or agents, and any other required information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the expenses incident
to the registration under the Securities Act of the offer and sale of our common stock covered by this prospectus by the Selling Stockholder.
As consideration for its irrevocable commitment to purchase our common stock under the Purchase Agreement, we have agreed to issue to
the Selling Stockholder 1.0% of the shares of common stock issued in each Fixed Purchase, VWAP Purchase or Additional VWAP Purchase, as
the case may be. We have also agreed to pay to the Selling Stockholder $25,000 in cash as reimbursement for the reasonable, out-of-pocket
expenses incurred by the Selling Stockholder, including the legal fees and disbursements of the Selling Stockholder&#8217;s legal counsel,
in connection with its due diligence investigation of the Company and in connection with the preparation, negotiation and execution of
the Purchase Agreement. See &#8220;<i><a href="#s1_007">The Committed Equity Financing</a></i>&#8221; for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also have agreed to indemnify
the Selling Stockholder and certain other persons against certain liabilities in connection with the offering of our common stock offered
hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to
be paid in respect of such liabilities. The Selling Stockholder has agreed to indemnify us against liabilities under the Securities Act
that may arise from certain written information furnished to us by the Selling Stockholder specifically for use in this prospectus or,
if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised
that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
represented to us that at no time prior to the date of the Purchase Agreement has the Selling Stockholder or its agents, representatives
or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule
200 of Regulation SHO of the Exchange Act) of our common stock or any hedging transaction, which establishes a net short position with
respect to our common stock. The Selling Stockholder has agreed that during the term of the Purchase Agreement, neither the Selling Stockholder,
nor any of its agents, representatives or affiliates will enter into or effect, directly or indirectly, any of the foregoing transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have advised the Selling
Stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M
precludes the Selling Stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution
from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution
until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a
security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered
by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This offering will terminate
on the date that all of our common stock offered by this prospectus have been sold by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="s1_013"></span>DESCRIPTION OF CAPITAL STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to issue
40,000,000 shares of common stock, par value $0.01 per share, and 4,000,000 shares of preferred stock, par value $0.01 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to issue
40,000,000 shares of common stock, par value $0.01 per share. The holders of common stock are entitled to one vote per share on all matters
submitted to a vote of stockholders, including the election of directors. There is no cumulative voting in the election of directors.
In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment
of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive
rights and have no right to convert their common stock into any other securities and there are no redemption provisions applicable to
our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of common stock
are entitled to any dividends that may be declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) out of funds legally
available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions we have
against the payment of dividends on common stock. We do not plan to pay dividends on our common stock in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As
of June 9, 2025, we had 1,125,998 shares of common stock outstanding. In addition, as of that date, there were approximately 251,000
shares of common stock issuable upon exercise of outstanding warrants and stock options.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_014"></span>CERTAIN PROVISIONS OF NEW YORK LAW AND OF OUR
CHARTER AND BYLAWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover Effects of New York Law</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 912 of the New York
Business Corporation Law (the &#8220;NYBCL&#8221;) prohibits a business combination, such as a merger, consolidation, recapitalization,
asset sale or disposition of stock, with any &#8220;interested shareholder&#8221; for a period of five years from the date that the interested
shareholder first became an interested shareholder unless:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the business combination, or the acquisition of stock that resulted in the interested shareholder first
becoming an interested shareholder, was approved by Forward&#8217;s Board   prior to the interested shareholder becoming an
interested shareholder;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the business combination is approved by the disinterested stockholders at a meeting of Forward&#8217;s
stockholders called no earlier than five years after the date that the interested shareholder first became an interested shareholder;
or</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: left">the business combination meets certain &#8220;fair price&#8221; valuation requirements.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">An &#8220;interested stockholder&#8221;
is any person that is the beneficial owner of 20% or more of the outstanding voting stock of Forward or is an affiliate or associate of
Forward that at any time during the prior five years was the beneficial owner, directly or indirectly, of 20% or more of the then outstanding
voting stock of Forward. The definition of &#8220;combination&#8221; contained in the statute is sufficiently broad to cover virtually
any kind of transaction that would allow a potential acquirer to use the corporation&#8217;s assets to finance the acquisition or otherwise
to benefit its own interests rather than the interests of the corporation and its other stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The effect of New York&#8217;s
business combination law is to potentially discourage parties interested in taking control of the Company from doing so if they cannot
obtain the approval of our Board or stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, under New York law
(a) directors may be removed for cause by vote of the stockholders, and (b) directors may be removed without cause by vote of the stockholders
only if specifically authorized by the Certificate of Incorporation or bylaws. Further, removal of directors with or without cause is
subject to: (1) if a corporation has cumulative voting, no director may be removed when the votes cast against such director&#8217;s removal
would be sufficient to elect such director if voted cumulatively at an election at which the same total number of votes were cast and
the entire Board, or class of directors of which he is a member, were then being elected; and (2) when, pursuant to the certificate of
incorporation, the holders of any class of shares are entitled to elect one or more directors, any director so elected may be removed
only by the vote of the holders of such class. Any such removal requires the affirmative vote of stockholders representing not less than
two-thirds of the voting power of the shares entitled to vote.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certificate of Incorporation and Bylaws</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Provisions of our Certificate
of Incorporation and Bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our
management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our
stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common
stock. Among other things, our Certificate of Incorporation and Bylaws:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 3%; text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt; width: 94%">permit our Board to issue up to 4,000,000 shares of preferred stock, without further stockholder approval, with such rights, preferences and privileges as our Board may designate in accordance with applicable law, including rights relating to acquisitions or changes in control;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that the authorized number of directors may be changed only by a resolution adopted by the Board;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that, for interim periods before the next meeting of the stockholders held for the election of directors, all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that special meetings of stockholders may be called only by the President, the Chairman of the Board, by the Board of Directors pursuant to a resolution adopted by the majority of the &#8220;entire board&#8221; (as defined in the  Bylaws), or Qualified Shareholders (as defined in the Bylaws) holding at least 30% of all votes entitled to be cast on any issue proposed to be considered at the special meeting;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide advance notice provisions applicable to a stockholder who wishes to nominate a director or propose other business to be considered at a stockholders&#8217; meeting.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Listings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is traded
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Transfer Agent</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent for our
common stock is Equiniti Trust Company, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Disclosure of Commission Position on Indemnification
for Securities Act Liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing
provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b></b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_015"></span>LEGAL MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
offered hereby will be passed upon for us by Nason, Yeager, Gerson, Harris &amp; Fumero, P.A., Palm Beach Gardens, Florida.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_016"></span>EXPERTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Forward Industries, Inc. and Subsidiaries for the years ended September 30, 2024 and 2023, have been audited by CohnReznick
LLP, independent registered public accounting firm, as set forth in their report thereon appearing in Forward Industries, Inc. and Subsidiaries&#8217;
Annual report on Form 10-K for the year ended September 30, 2024, and incorporated by reference herein. Such consolidated financial statements
are incorporated by reference herein in reliance upon such report, which includes an explanatory paragraph on Forward Industries, Inc.
and Subsidiaries&#8217; ability to continue as a going concern, given on the authority of such firm as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_017"></span>Where You Can Find
More Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly,
and other reports, proxy statements and other information with the SEC. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q,
and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the
SEC pursuant to Section 13(a) or 15(d) of the Exchange Act are available free of charge on our website and through the SEC&#8217;s Electronic
Data Gathering, Analysis, and Retrieval system (EDGAR). The SEC maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC at&#160;https://www.sec.gov. You may access
the registration statement, of which this prospectus is a part, at the SEC&#8217;s website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We make available through
our website, free of charge, copies of our SEC filings as soon as reasonably practicable after we electronically file or furnish them
to the SEC on our website,&#160;https://www.forwardindustries.com. We have not incorporated by reference into this prospectus the information
on our website, and you should not consider it to be a part of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus forms part
of a registration statement we have filed with the SEC relating to, among other things, the common stock. As permitted by SEC rules, this
prospectus does not contain all the information we have included in the registration statement and the accompanying exhibits and schedules
we have filed with the SEC. You may refer to the registration statement, exhibits and schedules for more information about us and the
common stock. The statements this prospectus make pertaining to the content of any contract, agreement or other document that is an exhibit
to the registration statement necessarily are summaries of their material provisions, and we qualify them in their entirety by reference
to those exhibits for complete statements of their provisions. The registration statement, exhibits and schedules are available through
the SEC&#8217;s website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b><span id="s1_018"></span>INCORPORATION OF CERTAIN INFORMATION
BY REFERENCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC maintains an Internet
site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the
SEC at&#160;<i>www.sec.gov</i>. The SEC allows us to &#8220;incorporate by reference&#8221; the information in certain documents that
we file with it, which means that we can disclose important information to you by referring you to documents previously filed with the
SEC. The information incorporated by reference is considered to be part of this prospectus, and the information that we subsequently file
with the SEC will automatically update and supersede this information. This prospectus incorporates by reference the Company&#8217;s documents
listed below and all documents subsequently filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
prior to the termination of the offering of the securities described in this prospectus (other than documents or information deemed to
have been furnished and not filed in accordance with SEC rules, unless otherwise expressly incorporated by reference herein):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824009011/forward_i10k-093024.htm">Annual Report on Form 10-K</a> for Fiscal Year ended September 30, 2024 filed with the SEC on December 27,
2024 and <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000424/forward_10ka1-093024.htm">Form 10-K/A</a> for the fiscal year ended September 30, 2024 filed with the SEC on January 17, 2025;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our quarterly reports on Form 10-Q filed on <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000993/forward_i10q-123124.htm">February 13, 2025</a>, and <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003548/forward_i10q-033125.htm">May 14, 2025</a>;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our current reports on Form 8-K (including 8-K/A) filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824006943/forward_8k.htm">October 4, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824007224/forward_8k.htm">October 18, 2024</a>,
                                                            <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824007539/forward_8k.htm">November 1, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824008222/forward_8k.htm">November 18, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824008710/forward_8k.htm">December 13, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316824008908/forward_8k.htm">December 23, 2024</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000650/forward_8k.htm">February
                                                            3, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000992/forward_8k.htm">February 13, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001267/forward_8k.htm">February
                                                            27, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001658/forward_8k.htm">March 17, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001830/forward_8k.htm">March
                                                            24, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825002064/forward_8k.htm">March 31, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825002108/forward_8k.htm">March
                                                            31, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825002225/forward_8k.htm">April 2, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003025/forward_8k.htm">May
                                                            1, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003287/forward_8k.htm">May 8, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_8k.htm">May
                                                            22, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825003989/forward_8k.htm">May 23, 2025</a> and <a href="http://www.sec.gov/Archives/edgar/data/38264/000168316825004223/forward_8k.htm">June
                                                            4, 2025</a> (other than information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits relating to such information,
                                                            which is neither filed nor incorporated by reference herein); and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The description of our securities contained in <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316819004079/ford_ex0401.htm">Exhibit 4.1</a> to our Form 10-K
filed with the Commission on December 27, 2019, as updated by any amendments and reports filed for the purpose of updating such description;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that any information
contained in any Current Report on Form 8-K, or any exhibit thereto, was furnished, rather than filed, with the SEC, that information
or exhibit is specifically not incorporated by reference in this document.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may obtain copies of these
documents free of charge on our website, www.forwardindustries.com, as soon as reasonably practicable after they have been filed with
the SEC and through the SEC&#8217;s website, www.sec.gov. You may also obtain such documents by submitting a written request either to
the Company at 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, Attention: Kathleen Weisberg or an oral request by
calling the Company at (631) 547-3055. The Company will provide to each person, including any beneficial owner, to whom a prospectus is
delivered, a copy of any or all of the reports that have been incorporated by reference in the prospectus contained in the registration
statement but not delivered with the prospectus upon oral or written request, at no cost to the requester, by contacting the Company as
noted above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Forward Industries, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Offering of 273,000 shares
of common stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>_______ __, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INFORMATION NOT REQUIRED IN THE PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 13. Other Expenses of Issuance and Distribution.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the costs and expenses payable by us in connection with the issuance and distribution of the securities being registered hereunder. All
of the amounts shown are estimates, except for the SEC Registration Fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; font-size: 10pt">SEC registration fees</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">258.30</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 82%; text-align: justify; font-size: 10pt">Printing expenses</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">$</td>
    <td style="width: 15%; text-align: right; font-size: 10pt">(1)</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; font-size: 10pt">Accounting fees and expenses</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">(1)</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; font-size: 10pt">Legal fees and expenses</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">(1)</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">Miscellaneous</td>
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">$</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; font-size: 10pt">(1)</td>
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">Total</td>
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: justify; font-size: 10pt">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 10pt">(1)</td>
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 14. Indemnification of Directors and Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation
and Bylaws provide for indemnification of our officers, directors and agents to the fullest extent permitted under the NYBCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 721 provides
that the indemnification and advancement of expenses granted pursuant to, or provided by, this article shall not be deemed exclusive of
any other rights to which a director or officer seeking indemnification or advancement of expenses may be entitled, whether contained
in the certificate of incorporation or the by-laws or, when authorized by such certificate of incorporation or by-laws, (i) a resolution
of shareholders, (ii) a resolution of directors, or (iii) an agreement providing for such indemnification, provided that no indemnification
may be made to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes
that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action
so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Nothing
contained in this article shall affect any rights to indemnification to which corporate personnel other than directors and officers may
be entitled by contract or otherwise under law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 722(a) provides
that a corporation shall indemnify any director or officer of a corporation against judgments, fines, amounts paid in settlement, and
expenses, including attorneys&#8217; fees, actually and necessarily incurred by such person in connection with the defense of any action,
suit or proceeding to the extent that such director or officer acted in good faith and in a manner not opposed to the best interests of
the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 722(b) provides
that a corporation may indemnify any person made, or threatened to be made, a party to an action by or in the right of the corporation
to procure a judgment in its favor by reason of the fact that he, his testator or intestate, is or was a director or officer of the corporation,
or is or was serving at the request of the corporation as a director or officer of any other corporation of any type or kind, domestic
or foreign, of any partnership, joint venture, trust, employee benefit plan or other enterprise, against amounts paid in settlement and
reasonable expenses, including attorneys&#8217; fees, actually and necessarily incurred by him in connection with the defense or settlement
of such action, or in connection with an appeal therein, if such director or officer acted, in good faith, for a purpose which he reasonably
believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan
or other enterprise, not opposed to, the best interests of the corporation, except that no indemnification under this paragraph shall
be made in respect of (1) a threatened action, or a pending action which is settled or otherwise disposed of, or (2) any claim, issue
or matter as to which such person shall have been adjudged to be liable to the corporation, unless and only to the extent that the court
in which the action was brought, or, if no action was brought, any court of competent jurisdiction, determines upon application that,
in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such portion of the settlement
amount and expenses as the court deems proper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 723 provides
that a person who has been successful, on the merits or otherwise, in the defense of a civil or criminal action or proceeding of the character
described in Section 722, or in defense of any claim, issue or matter therein, shall be entitled to indemnification as authorized in such
section. Except as provided in the immediately preceding sentence, any indemnification provided for in Section 722 or otherwise permitted
by Section 721, (unless ordered by a court under Section 724 of the NYBCL), shall be made by the Corporation only if authorized in the
specific case:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) By the board of directors
acting by a quorum consisting of directors who are not parties to such action or proceeding for which indemnification is sought, upon
a finding that the person seeking indemnification has met the standard of conduct set forth in Section 722 or established pursuant to
Section 721 or,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) If a quorum under the
immediately preceding subparagraph is not obtainable or, even if obtainable, a quorum of disinterested directors so directs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) by the board upon the
opinion in writing of independent legal counsel that indemnification is proper in the circumstances because the applicable standard of
conduct set forth in said first two paragraphs has been met by such person, or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) by the shareholders upon
a finding that the person has met the applicable standard of conduct set forth in said first two paragraphs.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing
provisions, the SEC has taken the position that, such indemnification is against public policy as expressed in the Securities Act and
is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit
or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will,
unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question of whether such indemnification by us is against public policy as expressed in the Securities Act and we will be governed
by the final adjudication of such issue.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 15. Recent Sales of Unregistered Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following list sets forth information regarding
all securities sold or granted by us within the last three years that were not registered under the Securities Act and the consideration,
if any, received by us for such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective May 16, 2025, the Company issued the
Commitment Shares to the Selling Stockholder. The Commitment Shares were issued without registration under the Securities Act, in reliance
on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated
under the Securities Act as a sale to an accredited investor, and in reliance on similar exemptions under applicable state laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 16. Exhibits and Financial Statement Schedules</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) See the Exhibit Index on the page immediately
preceding the signature page hereto for a list of exhibits filed as part of this registration statement on Form S-1, which Exhibit Index
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) No financial statement schedules are provided
because the information called for is not required or is shown either in the financial statements or the notes thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 17. Undertakings </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned registrant
hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during any period
in which offers or sales are being made, a post-effective amendment to this registration statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) To include any prospectus
required by section 10(a)(3) of the Securities Act;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) To reflect in the prospectus
any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration
Fee&#8221; table in the effective registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) To include any material
information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to
such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if
the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished
to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule
424(b) that is part of the registration statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) That, for the purpose
of determining liability under the Securities Act to any purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) Each prospectus filed
by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus
was deemed part of and included in the registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) Each prospectus required
to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities
Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is
first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As
provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed
to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus
relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.&#160;<i>Provided</i>,&#160;<i>however</i>,
that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for purposes of
determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or 15(d)
of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating
to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(6) Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant
to any charter provision, by law or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 9pt"><b>Incorporated by Reference</b></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-size: 9pt"><b>Exhibit<br/>
    No.</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 54%"><span style="font-size: 9pt"><b>Exhibit Description</b></span></td>
    <td style="text-align: justify; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 8%"><span style="font-size: 9pt"><b>Form</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 10%"><span style="font-size: 9pt"><b>Date</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 9%"><span style="font-size: 9pt"><b>Number</b></span></td>
    <td style="text-align: justify; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 8%"><span style="font-size: 9pt"><b>Filed or<br/>
    Furnished<br/>
    Herewith</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329718000005/ex2-1.htm">Stock
    Purchase Agreement dated January 18, 2018 - Intelligent Product Solutions, Inc.+</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">1/18/18</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">2.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316820002782/forward_8k-ex9901.htm">Asset
    Purchase Agreement dated August 17, 2020 - Kablooe, Inc.+</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8/17/20</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329710000300/exhibit3i.htm">Restated
    Certificate of Incorporation</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/8/10</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3(i)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329713000150/es3-1.htm">Certificate
    of Amendment of the Certificate of Incorporation - Series A Participating Preferred Stock </a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4/26/13</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329713000316/es3-1.htm">Certificate
    of Amendment of the Certificate of Incorporation - 6% Senior Convertible Preferred Stock</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/3/13</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004362/forward_ex0301.htm">Certificate
    of Amendment of the Certificate of Incorporation - Reverse Stock Split</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">6/20/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004696/forward_ex0401.htm">Certificate
    of Amendment of the Certificate of Incorporation - Series A-1 Convertible Preferred Stock</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/8/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.6</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824006943/forward_ex0401.htm">Certificate
    of Amendment of the Certificate of Incorporation - Increasing the Authorized Series A-1</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10/4/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.7</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex0307.htm">Certificate of Amendment of the Certificate of Incorporation &#8211; Series B</a></span> **</td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.8</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329714000579/ex3-ii.htm">Third
    Amended and Restated Bylaws, as of May 28, 2014</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/10/14</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3(ii)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316819004079/ford_ex0401.htm">Description
    of securities registered under Section 12 of the Exchange Act of 1934</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/27/19</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">4.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_ex1003.htm">Promissory Note dated January 18, 2018 - Forward Industries (Asia-Pacific) Corporation (as amended and restated)</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">5.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex0501.htm">Opinion of Nason Yeager Gerson Harris &amp; Fumero P.A.</a> **</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329719000016/exhibit4-3.htm">2011
    Long-Term Incentive Plan, as amended</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-Q</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2/14/19</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316820004438/forward_ex0401.htm">2021
    Equity Incentive Plan</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/23/20</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316821006416/forward_ex1004a.htm">Form
    of Employment Agreement dated May 26, 2021 - Paul Severino</a>*</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/21</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329718000112/ex10-5.htm">Summary
    of Employment Arrangement - Terence Wise*</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/21/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316820002160/forward_8k-ex1001.htm">Employment
    Agreement dated July 1, 2023 - Kathleen Weisberg*</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">6/30/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.9</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822003502/forward_ex1001.htm">Consultancy
    Agreement dated March 1, 2022 - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-Q</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/12/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.10</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1011.htm">Consultancy
    Agreement dated September 1, 2022 - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.11</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.10(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1004.htm">Extension
    to the Consultancy Agreement - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.11</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1012.htm">Employment
    Agreement dated January 18, 2018 - Robert Wild</a> *</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.12</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.12</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1013.htm">Employment
    Agreement dated August 17, 2020 - Tom KraMer</a> *</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.13</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.13</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1001.htm">Buying
    Agency and Supply Agreement dated November 2, 2023 - Forward Industries (Asia-Pacific) Corporation</a>+</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.13(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824008222/forward_ex1001.htm">Amendment
    to the Buying Agency and Supply Agreement - November 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/18/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.14</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1002.htm">Deferred
    Payment Agreement - Forward Industries (Asia - Pacific) Corporation</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.15</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004696/forward_ex1001.htm">Account
    Payables Conversion Agreement - Forward Industries (Asia- Pacific) Corporation - July 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/8/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.16</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824006943/forward_ex1001.htm">Account
    Payables Conversion Agreement - Forward Industries (Asia-Pacific) Corporation - September 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10/4/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.17</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_ex1004.htm">Securities Purchase Agreement dated May 16, 2025, by and between C/M Capital Master Fund, LP and Forward Industries, Inc. - ELOC</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.18</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_ex1005.htm">Registration Rights Agreement dated May 16, 2025, by and between C/M Capital Master Fund, LP and Forward Industries, Inc. - ELOC</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.19</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_ex1001.htm">OEM Transaction Agreement dated May 16, 2025</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.20</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex1020.htm">Form of Securities Purchase Agreement dated May 23, 2025 &#8211; Series B</a> **</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.21</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex1021.htm">Form of Registration Rights Agreement dated May 23, 2025 &#8211; Series B</a></span> **</td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.22</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex1022.htm">Form of Warrant dated May 23, 2025</a></span> **</td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">21.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex2101.htm">List of Subsidiaries</a></span> **</td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">23.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><a href="forward_s1a1-ex2301.htm"><span style="font-size: 9pt">Consent of Independent Registered Public Accounting Firm</span></a></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">23.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">Consent of Nason Yeager Gerson Harris &amp; Fumero P.A. (Contained in <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex0501.htm">Exhibit 5.1</a>)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">107</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825004372/forward_ex107.htm">Filing Fee Table</a> **</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 2pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">+</td><td style="text-align: justify">Certain schedules, appendices and exhibits to this agreement have
been omitted in accordance with Item 601 of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally
to the Securities and Exchange Commission staff upon request.</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 20pt; text-align: left">**</td><td style="text-align: justify">Previously filed with the Registration Statement on Form S-1 (File
No. 333-287906) on June 10, 2025.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Hauppauge, State of New York on June 17, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><b>FORWARD INDUSTRIES, INC.</b></td></tr>
  <tr>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 55%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 5%; text-align: justify">By:&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; width: 40%; text-align: justify"><span style="text-decoration: underline">/s/<i>Michael Pruitt</i></span></td></tr>
  <tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Michael Pruitt</td></tr>
  <tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Interim Chief Executive Officer (Principal Executive Officer)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><b>Signature</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 52%; text-align: center"><b>Title</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 21%; text-align: center"><b>Date</b></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Michael Pruitt</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Interim Chief Executive Officer </td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 17, 2025</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">Michael Pruitt</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Kathleen Weisberg</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Chief Financial Officer (Principal Financial and Accounting Officer)</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 17, 2025</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">Kathleen Weisberg</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Sharon Hrynkow </i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 17, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Sharon Hrynkow</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Keith Johnson</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 17, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Keith Johnson </td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Sangita Shah</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 17, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Sangita Shah</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoVFNmjY4o4RYaIr2XLpLg1I606P8m/tG6IIRCSe0+uEBOxobVpkOGyKnI4Yds12iMUWCOjLTE40u0ugTALvBrnWVs/rD8wpcBgYBZTWYb74HwYh1UCcj5Ty5mag4wTtYTjXkRfPSVbmwqtN7oBbSs4MnVs0Gt+jR9OuidL7WtIOiM7QzaBeCpH+Q1KxgoO9NBP4puDPE9FNBkqEhumexdcWe/RfknIGmxDnBvpf0cfzv5KYg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>forward_s1a1-ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consent of Independent Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the incorporation by reference in this Amendment No.
1 to the Registration Statement on Form S-1 (No. 333-287906) and related Prospectus, of our report dated December 27, 2024, with respect
to the consolidated financial statements of Forward Industries, Inc. and Subsidiaries as of September 30, 2024 and 2023, and for the years
then ended which report is included in the Annual Report on Form 10-K of Forward Industries, Inc. and Subsidiaries for the year ended
September 30, 2024, filed with the Securities and Exchange Commission. Our audit report includes an explanatory paragraph relating to
Forward Industries, Inc. and Subsidiaries ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also consent to the reference to our firm under the caption &ldquo;Experts.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ CohnReznick LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holmdel, New Jersey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 17, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ford-20250617.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa2M+aPty552GYkxvmR0fRmKnyYmtwR3/C80nBxmwSEJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:FORD="http://forwardindus.com/20250617" elementFormDefault="qualified" targetNamespace="http://forwardindus.com/20250617">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://forwardindus.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20250617_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20250617_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ford-20250617_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ford-20250617_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://forwardindus.com/role/Cover" xlink:href="ford-20250617.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://forwardindus.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? *X# 2(  A$! Q$!_\0
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< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001683168-25-004556-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-004556-xbrl.zip
M4$L#!!0    ( /J*T5J#T?%2*0,  .X+   1    9F]R9"TR,#(U,#8Q-RYX
M<V2U5MMRVC 0?>],_T'U:\8W&'(AD$Q++D,#30::3/K4$;9,-)$E5Y+!_'TE
MV^)FH$!;/\FK<\[N:G=EMZZSF( )X@(SVK9\Q[, H@$+,1VWK>>A_7G8Z78M
M<'WU\0-03^N3;8,[C$C8!#<LL+LT8I?@&XQ1$]PCBCB4C%^"%TA2;6%WF" .
M.BQ."))(;12>FN#4\0)@VWO(OB :,OX\Z,YEWZ1,1--UI].I0]D$3AE_%T[
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MI-+Y <2P:<>C% 4(1]-9'QI2[1.,JR2-,"V\7,EM:4?S+%K7@(!V34A:PJ!
M@=R!L!0!FID\Q"LP_R)8#,.EIO0#2\NJ'95*%B HIK<^3)3>"R2SK1 -U_",
M TN=W93M,5O=GP5T08#28ZYUU[:0-T#Q- -=LBS)]NIQNIOM9D6$I7%MB2LV
M('.:";,\"!8 4R8#A0PI'2J$7GI>WR5@F7J($6R.*7-+@-UDDX*F)B 2K,8
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M7IWSUC3N3.5S-Z&LZQ"X#SF+G(/]YT?>T-58&T5B4];$R9CRO/X?UF;/I-N
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M&H^2W+XZ >7."O=%\%*=W^:6M[73JCD(LL1PBGIN?.4\WNZQ(.%.#@QT>M"
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MSKXR^<PCW(4[./+-E7USSN[Y:(#]..YPI>V'/>\M5I=/) C.7 O;>OC3D1X
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ME$/^@Y$LXUMS#T+N,L8R<R;_<O4:T/@W6P%'3M8F\PA^FZ/= S5OD#)>=JK
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M'B>>D<8:U<:92PLBS%G5&D,F"V2. ?9H^"FE5<#/\_EH==EAKFIYJD^[Z8B
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MHF-<Q-4MIR4NG@4%9(V>CN!C64;Z@4!OP1+O)L'0:@R4HLL8#S25G:7E'M'
M3CDEBS.BD-:Z/K8(Y=D-/-CTNMCA+MX!M60Y\J$$T+2ZIN-6G*FM*-4"<KTE
M3C%'!LZ8DUQ&:5I%N]R9EH]HIM,OOX':"\6IT'0 =Q&>QF;#'1$&XIK\],X
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MZ"GO(O#@*!G$06@58O40;R,>6G$1:=LQ1\;T([CYTLK[NG:^1K^]#.,.O$[
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M8CB>(OHI\.W,(QPJ!$CAM\L/^0^+K>!SLE)$OIE@&4C%44@>UER4@*"-&#X
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MCL;6M59Y+JZ!Q^7C.T@QQM#3R-Y6\(N07*CIC?2 UIPIIF-J%UD=J;'G5=G
MK-=T1!A+0P\!0(?8&H,P[X>AZ%T*7%TO1A<83 4; &' '3_DQM+TG^FH"S2:
MDOD*PY<_AO6NJDB',2G9>Q>2$Q#Q_/&27'%,6+?C;:!@1[]1KJ<N(18HO(L>
M.HKF:]1P;O<GA[%SU!7!I^XEAN8B&04*\@UGK::A#B-U>M)0EO[,A$ R?7<X
MZL"KZ?)*)Z(E',AGV,5AN'FD;_H:6O#C%C^A?2*VT&&87D3,)+^#K!E(82$X
M%_[+^$),M"@8!*&?V-V<?B8<<FKGJ7<9: AXY8"Y)N9G)#KH9Q=1Y.B)CDOE
MG!0BU:G@^'S*W)R]N*')H"XUHEC?6=G7;2:<8IL)[/6@@QW!O@HU8S/G1.A.
M/VK&-?1?3 ZA1N$I.7YJ^V@Y*BVCL96PR1]''QPQCEK6@[XXC(':,[6@I$OB
M>LTY8C!;)<ML>J6>:F(P9"DI%::JI)=95E&+N.Q@TQCNVLT\">,@24"^-&ZG
MEEX%0^8HH]0T>,4D!(H&8Z=7[.C]L/=K@1B.CB527)TF4G_'*EMDR#-K A0.
MF!TR095(QZG$)9?,EV=(WXBA3_=8%2O9\TQ'*!&$3+I1));*^::VIHD3A@L=
M4LLV_!#[PX!X= I1-<9T+&5&29+A>BO%)S[[/Z@DY(M^^EQO1PX8CM-33F0:
MW&GNJL,B3_7R5<] *WW'RIIIVNPF/'(^@=K]KOVAP[CKA&!.TS HYJB$U#8Z
M,<[_[Q&0V!7\CQHSU\V1'.ZD4UBK9+^!.DQ4L :R/9=024OAA*VG*+;T <]N
M/T(2E1:N2O32YHXD><I7&856 F3ZX("="QKSG8[5NARK12Y*70-47S:G0F>C
MAI:MC=[JQHO>2Z2SP2B\M/G_^=&A9;[9W2V]0@"YFMB+;2@I$;$6\A5E@T14
MYY?K!E1#[.S#U)\''"\T)U2;@/T7%*AYG20:)D&<* &N<XG2*\1/+VOSN4I3
MW\X]A5FTO%9[R]O;VVW,J[4J3V.=@. P&ZMOY5+9<4EKJXTE:;GSQS$)FC[?
M")S[H#O%@_)+_<++E:?Y#N*RGWKI/85NY7Y45<1J>H\[,[TUFM(/O201M+K/
MD;N0_ BUW2B=6=TVRB/1%[G.4Z7AN6UF+K.Z@K'W8VRMH<06%_:F3HZU58B7
M:=G:!64U/^[2 ?$\5MI6<7RB\0$%PQ/6N-CX*':4J>RD2%%\CGBCCC;D[&'@
M8\SVFUP@1L>LM+'Q]MY1;OD3.?Z?;=SI <7V^C*@^  !Q9UE0/%97KC3$!O[
ME-QC[!QSZIQCK3;^TJ>LJO?HP DZ%+%0+5"5WQM=1'WN]#6?LT$'0P8BNXIE
M1I,:AW^6@F&FI<0#<\BY^,;L<YN-P\S=4&%&EDE\:RP8#JD#QU+-3I!5D!^D
M"L\]SQHJWBCW2\^B-<SS"#UI#62_70=D?^,%E%TY!-6?]^><H"7(GY\JF^]$
MVGO%=58LJF(V=?S[3G:I%N[_IKMT]XZO1[AK]TY;3$#%+2/:DJTD[I*F9@7U
MJT;A:1[\SNBO8=OFP@B;8[H/N#+96Z1Y96X!?FIQ2[OAJQX]J6P\7U+9O/'2
M;H/YF5QV7K0W=CWYOY>UB(#MK1HSY/#59ZNV#,.E[@<8P',_G?*B*LV*]HR=
M,ZJLJ$9SJ57\C;17VIO>7GNO[D?SC[/X!:RU?WW*T]_90*2&)[R")SWWFY/.
MW2+$S9J?^ZA;VU4BIU9:G 4^KR> [85([YD5%+7N17OXIONRE^4&$0VMR@'7
M@ZCPA90D) OU5TA'53^AS^U?K.P?3PM%UL4<QX*V[J;_4/Q9_*"89<^ XE2$
M:TJ!Q.IH83D>,RV\?ZOYDQ]=]C?']" 5CVH*47F8X:9CBW8&EMW;',P[3 Z&
MY<K>TH6FY?@] TS>:@%9;.&44,:13[%)&7NHFCV'O[(@[7.B$LZ<\6PP7PN3
MP1*<-D97@YZ.EC;E.-YF 53]%X=V22$.9Z<NPL7T,XX.<F*-R2#-AV H\U %
MNQ,Q@*W O[@;:8!):1_8 3>($QG7I*#LK1:@MAC80B%N"N1='U3U4RM<ZU4
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MGH\U12CDC_A$R'CU-!&:BL&"H4A#$, :6B-ZDA>7H,!:SQ.U555,HJ.#T];
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M[N&F*6,EGS2.X;YTQQ4(D4KY<D*M]RLQ.4/*EM1/ELJ:X 0;=91W-:*AG1Q
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M_WC+!XP_BD*J+78&B[=CT"E HN11CCE(FIB74TX-0W>9@-C]BE $5*1V+\$
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MICO(I^YFTI)#]OVYVJI7A"$KM4##2?5ZMT7'K%1'D+7'VX)#ZVR:9[X6VYA
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M^>47#I%JQ[='^&\_&K@?_C]02P,$%     @ ^HK16G VTD%#"   0 D   T
M  !I;6%G95\P,#$N:G!GG=1G4-/I%@?@?TBC!#$0>@NA2T 30A4(Q0!9L2 H
M15; 4.4"AEX45#8@18IQ4:ITI$5A T@1Z=@0,2ZA6 D(PHJTT,O%G5N^W-E9
M[^^=]],Y<V:>><ON\.Y'8/]/EF1+  0" 6Y["]@= RP 7A@,#H/RPN%P/CY>
M?@1*$"$@@) 4%A%"R4K)R\E*R<B@E;14T1BLHHR,FIXZ]A".0"#(JQH8Z^.-
MM+0)^.]#0+Q\? @!A(2@H 1>048!_\/9;0>0O( KP "#,  /$@1&@G:[ 7D
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MN7$-*I7RD: IQVE_O)^!K2%\\7@5ZBF$&CSBZ/R$>/7./O%&D^)7+*. U8W
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M]KVG:(JR)0$_NF-W1_X)4$L! A0#%     @ ^HK16H/1\5(I P  [@L  !$
M             ( !     &9O<F0M,C R-3 V,3<N>'-D4$L! A0#%     @
M^HK16O-;FUC]"@  ?X8  !4              ( !6 ,  &9O<F0M,C R-3 V
M,3=?;&%B+GAM;%!+ 0(4 Q0    ( /J*T5KT )1K6 <  -Q7   5
M      "  8@.  !F;W)D+3(P,C4P-C$W7W!R92YX;6Q02P$"% ,4    " #Z
MBM%:0GC0YH<"   !"   %P              @ $3%@  9F]R=V%R9%]S,6$Q
M+65X,C,P,2YH=&U02P$"% ,4    " #ZBM%:LLL"HR&L   G&P4 $
M        @ '/&   9F]R=V%R9%]S,6$Q+FAT;5!+ 0(4 Q0    ( /J*T5IP
M-M)!0P@  $ )   -              "  1[%  !I;6%G95\P,#$N:G!G4$L%
3!@     &  8 @P$  (S-      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>forward_s1a1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ford-20250617.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
        </entity>
        <period>
            <startDate>2025-06-17</startDate>
            <endDate>2025-06-17</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-17" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-17" id="Fact000004">0000038264</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-17" id="xdx2ixbrl0009">S-1/A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-17" id="Fact000010">Forward     Industries, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-17" id="Fact000011">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-17" id="Fact000012">13-1950672</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-17" id="Fact000013">700 Veterans Memorial Highway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-17" id="Fact000014">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-17" id="Fact000015">Hauppauge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-17" id="Fact000016">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-17" id="Fact000017">11788</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-17" id="Fact000018">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-17" id="Fact000019">547-3055</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="AsOf2025-06-17" id="Fact000020">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="AsOf2025-06-17" id="Fact000021">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-17" id="Fact000022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Forward
    Industries, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000038264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1950672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">700 Veterans Memorial Highway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hauppauge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">547-3055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>16</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="forward_s1a1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forwardindus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ford-20250617.xsd</File>
    <File>ford-20250617_lab.xml</File>
    <File>ford-20250617_pre.xml</File>
    <File doctype="S-1/A" isOnlyDei="true" isUsgaap="true" original="forward_s1a1.htm">forward_s1a1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forward_s1a1.htm": {
   "nsprefix": "FORD",
   "nsuri": "http://forwardindus.com/20250617",
   "dts": {
    "schema": {
     "local": [
      "ford-20250617.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ford-20250617_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ford-20250617_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "forward_s1a1.htm"
     ]
    }
   },
   "keyStandard": 16,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 16
   },
   "report": {
    "R1": {
     "role": "http://forwardindus.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-17",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_s1a1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-17",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_s1a1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
